Medicine
Effexor XR 75 mg extended-release capsule
Effexor XR 75 mg extended-release capsule is a prescription medicine containing Venlafaxine for oral use, marketed by Viatris Specialty, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at controlled room temperature, 20° to 25°C (68° to 77°F).
Key facts
- Active ingredient (INN)
- Venlafaxine
- Brand
- Effexor XR
- Strength
- 75 mg
- Dosage form
- Extended-release capsule
- Route
- Oral
- Packs
- 90 capsules, 30 capsules
- Marketing authorisation holder
- Viatris Specialty
- Manufacturer
- Viatris Specialty
- Origin register
- US FDA, United States
- Storage
- Store at controlled room temperature, 20° to 25°C (68° to 77°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- N06AX16 Venlafaxine
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 30 October 2024
- Identifiers
- RxCUI 313581, 313583, 313585 +3DailyMed set ID c848a5d8-ba94-4c84-80e3-0bf35fb8e32eNDC 58151-126Application NDA020699
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 90 capsule, extended release in 1 bottle | 58151-126-77 | Viatris Specialty | 30 October 2024 |
| 30 capsule, extended release in 1 bottle | 58151-126-93 | Viatris Specialty | 30 October 2024 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 28 December 1993 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Venlafaxine 75 mg extended-release capsule.
Other strengths and forms of Venlafaxine
Clinical summary
Venlafaxine is a serotonin and norepinephrine reuptake inhibitor indicated in adults for the treatment of major Depressive Disorder (MDD), among other approved uses. It is available as extended-release capsules, tablets and extended-release tablets for oral use. MedsAcross supplies Venlafaxine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about VenlafaxineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Effexor XR prescribing information (Viatris Specialty) · U.S. National Library of Medicine, DailyMed
Need Effexor XR 75 mg extended-release capsule for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.